Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study

M. Piazza, N. M. J. Hanssen, F. Persson, J. L. Scheijen, M. P. H. van de Waarenburg, M. M. J. van Greevenbroek, P. Rossing, P. Hovind, C. D. A. Stehouwer, H-H. Parving, C. G. Schalkwijk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number14405
Number of pages7
JournalDiabetic Medicine
Volume38
Issue number9
Early online date16 Oct 2020
DOIs
Publication statusPublished - Sep 2021

Keywords

  • RENIN-ANGIOTENSIN SYSTEM
  • GLYCATION END-PRODUCTS
  • INDIVIDUALS
  • NEPHROPATHY
  • PATHOLOGY

Cite this